SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq:LJPC) reported a net loss for the three months ended June 30, 2008 of $14.9 million, or $0.31 per share (on 48.3 million weighted-average shares), compared to a net loss of $13.5 million, or $0.34 per share (on 39.3 million weighted-average shares), for the same period in 2007. The Company reported a net loss for the six months ended June 30, 2008 of $28.6 million, or $0.65 per share (on 43.9 million weighted-average shares), compared to a net loss of $25.4 million, or $0.70 per share (on 36.0 million weighted-average shares), for the same period in 2007.
